Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
NCT ID:
NCT01853618
Group ID:
EG002
Title:
3/Arm B - Tremelimumab + TACE
Description:
Tremelimumab + Transarterial Catheter Chemoembolization (TACE)
Tremelimumab: 10 mg /kg intravenous (IV) every 4 weeks times 6 doses and then every 12 weeks for 2 years
TACE: Performed on Day 36 and may be repeated (as per standard of care) on months 3, 7, and 13, and every (q)6 months thereafter (if indicated)
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
7
Serious Number At Risk:
12
Other Number Affected:
12
Other Number At Risk:
12
Study:
NCT01853618
Results Section:
NCT01853618
Adverse Events Module:
NCT01853618